A detailed history of Northwestern Mutual Wealth Management CO transactions in Novo Nordisk A S stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 438,233 shares of NVO stock, worth $46.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
438,233
Previous 448,510 2.29%
Holding current value
$46.2 Million
Previous $64 Million 18.49%
% of portfolio
0.05%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$119.07 - $145.42 $1.22 Million - $1.49 Million
-10,277 Reduced 2.29%
438,233 $52.2 Million
Q2 2024

Aug 15, 2024

BUY
$122.71 - $146.91 $3.02 Million - $3.62 Million
24,646 Added 5.81%
448,510 $64 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $9.39 Million - $12.5 Million
91,989 Added 27.72%
423,864 $54.4 Million
Q4 2023

Feb 13, 2024

BUY
$87.78 - $105.45 $12.6 Million - $15.2 Million
143,908 Added 76.56%
331,875 $34.3 Million
Q3 2023

Nov 14, 2023

BUY
$90.94 - $199.54 $12.9 Million - $28.2 Million
141,363 Added 303.33%
187,967 $17.1 Million
Q2 2023

Aug 14, 2023

BUY
$155.98 - $172.65 $624,699 - $691,463
4,005 Added 9.4%
46,604 $7.54 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $616,704 - $741,592
4,660 Added 12.28%
42,599 $6.78 Million
Q4 2022

Feb 21, 2023

BUY
$102.55 - $135.33 $137,314 - $181,206
1,339 Added 3.66%
37,939 $5.13 Million
Q3 2022

Nov 14, 2022

SELL
$95.28 - $116.93 $202,374 - $248,359
-2,124 Reduced 5.48%
36,600 $3.65 Million
Q2 2022

Aug 04, 2022

BUY
$103.24 - $121.81 $233,528 - $275,534
2,262 Added 6.2%
38,724 $4.32 Million
Q1 2022

May 09, 2022

SELL
$93.1 - $112.54 $92,541 - $111,864
-994 Reduced 2.65%
36,462 $4.05 Million
Q4 2021

Feb 03, 2022

BUY
$95.88 - $117.08 $378,438 - $462,114
3,947 Added 11.78%
37,456 $4.2 Million
Q3 2021

Nov 15, 2021

BUY
$84.42 - $106.62 $13,760 - $17,379
163 Added 0.49%
33,509 $3.22 Million
Q2 2021

Aug 13, 2021

BUY
$67.66 - $84.76 $387,285 - $485,166
5,724 Added 20.72%
33,346 $2.79 Million
Q1 2021

May 14, 2021

BUY
$67.06 - $75.82 $1,207 - $1,364
18 Added 0.07%
27,622 $1.86 Million
Q4 2020

Feb 12, 2021

BUY
$63.89 - $73.8 $115,960 - $133,947
1,815 Added 7.04%
27,604 $1.93 Million
Q3 2020

Nov 13, 2020

SELL
$63.69 - $70.22 $13,183 - $14,535
-207 Reduced 0.8%
25,789 $1.79 Million
Q2 2020

Aug 14, 2020

SELL
$58.54 - $67.94 $82,717 - $95,999
-1,413 Reduced 5.16%
25,996 $1.7 Million
Q1 2020

May 08, 2020

SELL
$49.46 - $64.78 $93,627 - $122,628
-1,893 Reduced 6.46%
27,409 $1.65 Million
Q4 2019

Feb 13, 2020

BUY
$49.86 - $58.26 $135,918 - $158,816
2,726 Added 10.26%
29,302 $1.7 Million
Q3 2019

Nov 12, 2019

BUY
$47.54 - $53.43 $116,140 - $130,529
2,443 Added 10.12%
26,576 $1.37 Million
Q2 2019

Aug 12, 2019

BUY
$46.79 - $52.47 $51,422 - $57,664
1,099 Added 4.77%
24,133 $1.23 Million
Q1 2019

May 10, 2019

SELL
$46.36 - $52.63 $11,358 - $12,894
-245 Reduced 1.05%
23,034 $1.21 Million
Q4 2018

Feb 12, 2019

SELL
$41.54 - $47.25 $5,898 - $6,709
-142 Reduced 0.61%
23,279 $1.07 Million
Q3 2018

Nov 01, 2018

BUY
$46.76 - $51.24 $171,141 - $187,538
3,660 Added 18.52%
23,421 $1.1 Million
Q2 2018

Aug 10, 2018

BUY
$44.29 - $50.42 $17,184 - $19,562
388 Added 2.0%
19,761 $911,000
Q1 2018

May 14, 2018

SELL
$48.49 - $58.14 $134,414 - $161,164
-2,772 Reduced 12.52%
19,373 $954,000
Q4 2017

Jan 31, 2018

SELL
$47.53 - $53.73 $100,335 - $113,424
-2,111 Reduced 8.7%
22,145 $1.19 Million
Q3 2017

Nov 07, 2017

BUY
$41.15 - $49.22 $100,611 - $120,342
2,445 Added 11.21%
24,256 $1.17 Million
Q2 2017

Aug 10, 2017

BUY
N/A
21,811
21,811 $935,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $238B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.